Matches in Library of Congress for { <http://lccn.loc.gov/2003025020> ?p ?o. }
Showing items 1 to 27 of
27
with 100 items per page.
- 2003025020 contributor B9525628.
- 2003025020 created "c2004.".
- 2003025020 date "2004".
- 2003025020 date "c2004.".
- 2003025020 dateCopyrighted "c2004.".
- 2003025020 description "Antisense methodology / Fritz Eckstein -- Nucleic acid therapeutics / Alan M. Gewirtz -- Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer -- Therapeutic applications of ribozymes / John J. Rossi -- Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun -- Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga -- Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael -- The transport of oligonucleotides into cells / R.L. Juliano -- Peptide-mediated delivery of antisense oligonucleotides and related material / Eric Vivås, Jean Philippe Richard and Bernard Lebleu -- Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.] -- Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel -- Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz -- Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline -- LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.] -- Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung.".
- 2003025020 description "Includes bibliographical references and index.".
- 2003025020 extent "219 p. :".
- 2003025020 identifier "1588292584 (alk. paper)".
- 2003025020 identifier 2003025020-d.html.
- 2003025020 identifier 2003025020.html.
- 2003025020 isPartOf "Cancer drug discovery and development".
- 2003025020 issued "2004".
- 2003025020 issued "c2004.".
- 2003025020 language "eng".
- 2003025020 publisher "Totowa, N.J. : Humana Press,".
- 2003025020 subject "616.99/4061 22".
- 2003025020 subject "Antisense nucleic acids Therapeutic use.".
- 2003025020 subject "Cancer Chemotherapy.".
- 2003025020 subject "Gene Therapy methods Congresses.".
- 2003025020 subject "Neoplasms therapy Congresses.".
- 2003025020 subject "Nucleic Acids therapeutic use Congresses.".
- 2003025020 subject "QZ 267 N9638 2004".
- 2003025020 subject "RC271.A69 N83 2004".
- 2003025020 tableOfContents "Antisense methodology / Fritz Eckstein -- Nucleic acid therapeutics / Alan M. Gewirtz -- Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer -- Therapeutic applications of ribozymes / John J. Rossi -- Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun -- Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga -- Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael -- The transport of oligonucleotides into cells / R.L. Juliano -- Peptide-mediated delivery of antisense oligonucleotides and related material / Eric Vivås, Jean Philippe Richard and Bernard Lebleu -- Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.] -- Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel -- Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz -- Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline -- LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.] -- Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung.".
- 2003025020 title "Nucleic acid therapeutics in cancer / edited by Alan M. Gewirtz.".
- 2003025020 type "text".